Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Paclitaxel and Cisplatin for Thymic Neoplasm

This study has been terminated.
(marginal statistical significance)
Sponsor:
Information provided by (Responsible Party):
Se-Hoon Lee, Korean Cancer Study Group
ClinicalTrials.gov Identifier:
NCT00818090
First received: January 5, 2009
Last updated: April 11, 2013
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2011
  Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)